Profile data is unavailable for this security.
About the company
T2 Biosystems, Inc. is an in vitro diagnostics company focused on the detection of sepsis-causing pathogens and antibiotic resistance genes. Its technology enables detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection as low as one colony forming unit per milliliter (CFU/mL). Its focus includes three areas: sepsis, bioterrorism, and Lyme disease. The Company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the T2 Magnetic Resonance (T2MR) technology. It also has an active pipeline of products, including the United States T2Resistance Panel, the Candida auris test, and the T2Lyme Panel. T2Dx Instrument is a fully automated instrument that is capable of running a range of diagnostic tests from patient samples.
- Revenue in USD (TTM)7.16m
- Net income in USD-48.26m
- Incorporated2006
- Employees113.00
- LocationT2 Biosystems Inc101 Hartwell AveLEXINGTON 02421-3125United StatesUSA
- Phone+1 (781) 457-1200
- Fax+1 (781) 357-3080
- Websitehttps://www.t2biosystems.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Icecure Medical Ltd | 3.34m | -13.69m | 32.19m | 71.00 | -- | 3.03 | -- | 9.65 | -0.2934 | -0.2934 | 0.0714 | 0.2143 | 0.1753 | 0.8436 | 15.06 | 46,985.91 | -71.93 | -54.89 | -92.10 | -68.66 | 40.32 | 49.87 | -410.22 | -313.19 | 2.54 | -- | 0.00 | -- | 4.67 | 23.50 | 13.70 | -- | 48.10 | -- |
| SANUWAVE Health Inc | 24.90m | -3.43m | 33.08m | 31.00 | -- | -- | -- | 1.33 | -0.0095 | -0.0095 | 0.0218 | -0.0335 | 1.24 | 3.90 | 8.34 | 803,064.50 | -17.07 | -136.54 | -- | -- | 71.57 | 69.13 | -13.79 | -189.60 | 0.0999 | 0.1199 | -- | -- | 21.84 | 61.61 | -150.72 | -- | -- | -- |
| Vicarious Surgical Inc | 0.00 | -61.02m | 34.56m | 131.00 | -- | 0.4795 | -- | -- | -10.77 | -10.77 | 0.00 | 12.22 | 0.00 | -- | -- | 0.00 | -61.68 | -- | -66.62 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -1,478.15 | -- | -- | -- |
| United Health Products Inc | 0.00 | -1.84m | 34.73m | 6.00 | -- | -- | -- | -- | -0.0075 | -0.0075 | 0.00 | -0.0081 | 0.00 | 0.00 | -- | 0.00 | -662.95 | -6,446.86 | -- | -- | -- | 53.19 | -- | -132,561.20 | 0.0126 | -15.12 | -- | -- | -100.00 | -- | -55.45 | -- | -- | -- |
| Accelerate Diagnostics Inc | 12.23m | -37.91m | 34.81m | 134.00 | -- | -- | -- | 2.85 | -2.07 | -2.07 | 0.6853 | -1.47 | 0.3363 | 2.14 | 5.28 | 91,291.05 | -104.22 | -75.24 | -1,349.93 | -94.46 | 27.16 | 35.08 | -309.87 | -638.55 | 1.04 | -- | 6.38 | -- | -5.43 | 16.29 | 1.40 | -- | 0.7307 | -- |
| Vaso Corp | 80.33m | 2.26m | 35.08m | 300.00 | 12.96 | 1.31 | 11.19 | 0.4367 | 0.0154 | 0.0154 | 0.4571 | 0.1524 | 1.10 | 22.59 | 9.62 | 267,766.70 | 3.10 | 7.60 | 5.04 | 16.62 | 61.20 | 58.39 | 2.81 | 5.82 | 1.48 | -- | 0.0028 | -- | 2.18 | 1.84 | -57.46 | -- | -22.33 | -- |
| Movano Inc | 852.00k | -26.83m | 35.62m | 30.00 | -- | 2.12 | -- | 41.81 | -0.4527 | -0.4527 | 0.0131 | 0.1696 | 0.0444 | -- | 3.38 | 28,400.00 | -139.74 | -151.50 | -176.37 | -188.58 | -87.21 | -- | -3,149.06 | -- | 5.23 | -- | 0.0025 | -- | -- | -- | 3.45 | -- | 4.24 | -- |
| BioNano Genomics Inc | 36.58m | -204.10m | 36.12m | 344.00 | -- | 0.37 | -- | 0.9874 | -5.15 | -5.15 | 0.7496 | 1.14 | 0.1826 | 1.00 | 5.28 | 106,334.30 | -101.86 | -56.82 | -123.67 | -67.83 | 28.97 | 25.38 | -557.98 | -505.76 | 1.11 | -61.51 | 0.0455 | -- | 29.90 | 24.65 | -75.34 | -- | 38.51 | -- |
| Precision Optics Corporation Inc | 19.41m | -1.64m | 37.15m | 84.00 | -- | 3.15 | -- | 1.91 | -0.2706 | -0.2706 | 3.24 | 1.86 | 1.06 | 4.30 | 4.51 | 231,098.50 | -8.98 | -6.71 | -13.18 | -10.55 | 33.65 | 33.65 | -8.43 | -5.02 | 1.05 | -8.86 | 0.1982 | -- | 34.23 | 39.12 | 84.42 | -- | 19.39 | -- |
| Rapid Micro Biosystems Inc | 24.71m | -50.46m | 37.29m | 193.00 | -- | 0.3942 | -- | 1.51 | -1.17 | -1.17 | 0.5711 | 2.20 | 0.1778 | 1.33 | 5.58 | 128,036.30 | -36.30 | -- | -40.86 | -- | -14.22 | -- | -204.22 | -- | 4.62 | -- | 0.003 | -- | 31.44 | -- | 13.71 | -- | -- | -- |
| Apyx Medical Corp | 49.03m | -28.37m | 37.76m | 252.00 | -- | 2.56 | -- | 0.7702 | -0.8188 | -0.8188 | 1.42 | 0.4257 | 0.7672 | 1.82 | 3.96 | 194,567.50 | -44.55 | -25.24 | -58.21 | -29.97 | 61.90 | 66.11 | -58.08 | -46.00 | 4.45 | -7.79 | 0.693 | -- | 17.61 | 25.82 | 19.28 | -- | 7.99 | -- |
| T2 Biosystems Inc | 7.16m | -48.26m | 38.46m | 113.00 | -- | -- | -- | 5.37 | -10.70 | -10.70 | 1.09 | -0.3391 | 0.2435 | 2.82 | 5.41 | 63,398.23 | -164.01 | -106.01 | -- | -253.03 | -86.96 | -12.60 | -673.67 | -317.93 | 0.359 | -12.44 | 2.00 | -- | -67.75 | -7.29 | 19.66 | -- | -20.19 | -- |
| electroCore, Inc. | 21.28m | -14.23m | 38.69m | 68.00 | -- | 3.37 | -- | 1.82 | -2.19 | -2.19 | 3.25 | 1.78 | 1.16 | 1.41 | 54.85 | 312,955.90 | -77.78 | -70.73 | -125.05 | -88.96 | 83.61 | 75.81 | -66.84 | -352.82 | 2.12 | -- | 0.00 | -- | 86.57 | 74.42 | 15.02 | -- | -5.88 | -- |
| Co-Diagnostics Inc | 9.14m | -37.57m | 40.53m | 155.00 | -- | 0.5598 | -- | 4.44 | -1.27 | -1.27 | 0.3077 | 2.27 | 0.0944 | 1.19 | 11.08 | 58,948.20 | -38.83 | 5.77 | -41.04 | 6.15 | 59.83 | 82.24 | -411.19 | 10.94 | 8.81 | -- | 0.00 | 0.00 | -80.09 | 179.54 | -148.15 | -- | 101.27 | -- |
| iCAD Inc | 18.80m | -4.54m | 41.40m | 67.00 | -- | 1.33 | -- | 2.20 | -0.1735 | -0.088 | 0.7185 | 1.17 | 0.4488 | 1.06 | 3.14 | 280,537.30 | -10.84 | -23.94 | -13.90 | -34.14 | 86.04 | 76.96 | -24.16 | -45.02 | 4.13 | -- | 0.00 | -- | -12.54 | -7.53 | 29.32 | -- | 23.88 | -- |
| Lucid Diagnostics Inc | 3.80m | -54.15m | 44.20m | 70.00 | -- | -- | -- | 11.63 | -1.23 | -1.23 | 0.0857 | 0.3238 | 0.0992 | -- | 38.97 | 54,285.71 | -121.82 | -- | -274.96 | -- | -67.39 | -- | -1,227.76 | -- | 1.71 | -- | 0.4178 | -- | 544.03 | -- | 6.24 | -- | -- | -- |
Data as of Sep 20 2024. Currency figures normalised to T2 Biosystems Inc's reporting currency: US Dollar USD
13.43%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Armistice Capital LLCas of 30 Jun 2024 | 1.66m | 9.49% |
| The Vanguard Group, Inc.as of 30 Jun 2024 | 311.44k | 1.78% |
| Geode Capital Management LLCas of 30 Jun 2024 | 130.39k | 0.75% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 78.30k | 0.45% |
| SSgA Funds Management, Inc.as of 30 Jun 2024 | 63.74k | 0.37% |
| Susquehanna Financial Group LLLPas of 30 Jun 2024 | 41.66k | 0.24% |
| Northern Trust Investments, Inc.(Investment Management)as of 30 Jun 2024 | 38.88k | 0.22% |
| Goldman Sachs & Co. LLC (Private Banking)as of 30 Jun 2024 | 14.71k | 0.08% |
| Tower Research Capital LLCas of 30 Jun 2024 | 7.67k | 0.04% |
| RBC Dominion Securities, Inc.as of 30 Jun 2024 | 2.86k | 0.02% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
